Blood Bank Analyzer
ID: 12230641Type: Sources Sought
Overview

Buyer

DEPT OF DEFENSEDEFENSE HEALTH AGENCY (DHA)DEFENSE HEALTH AGENCYFALLS CHURCH, VA, 22042, USA

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

PSC

LABORATORY EQUIPMENT AND SUPPLIES (6640)

Set Aside

8(a) Set-Aside (FAR 19.8) (8A)

Original Source

https://sam.gov/opp/2ca0fceeda9546faa511fc94739fd70c/view
Timeline
    Description

    The Department of Defense, through the Defense Health Agency (DHA), is seeking qualified vendors for the procurement of a Blood Bank Analyzer, aimed at enhancing immunohematology testing capabilities at the A.T. Augusta Military Medical Center in Fort Belvoir, Virginia. The analyzer must automate various blood bank test processes and meet specific performance specifications, including the use of agglutination technology, the ability to perform fully automated serial dilutions, and compliance with FDA regulations for reagents. This procurement is critical for ensuring efficient and accurate blood testing, which is vital for patient care in military medical facilities. Interested parties must submit their capabilities statements by 9:00 AM EST on January 31, 2025, and can direct inquiries to Contract Specialist Pamela Renteria at pamela.i.renteria.civ@health.mil.

    Point(s) of Contact
    Pamela Renteria
    pamela.i.renteria.civ@health.mil
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    Blood Bank Analyzer
    Currently viewing
    Sources Sought
    Similar Opportunities
    Automated Blood Gas Analyzer Cost Per Test, Reagents and Supplies
    Buyer not available
    The Department of Defense, specifically the Army's Medical Readiness Contracting Office-East, is soliciting bids for the procurement of a Rapidpoint 500e Analyzer along with associated reagents and supplies for Martin Army Community Hospital located in Fort Moore, Georgia. This request for quotation (RFQ) aims to enhance laboratory capabilities for blood testing through a contract that includes both a base period and an option period for equipment lease and necessary supplies. The initiative underscores the government's commitment to medical readiness and improved laboratory services, with quotes due by March 19, 2024, and an estimated delivery date set for April 1, 2025. Interested vendors must comply with the NAICS size standard of 1250 employees in the In-Vitro Diagnostic Substance Manufacturing sector and can reach out to primary contact Johnnie Huffin at johnnie.huffin.civ@health.mil or secondary contact Gloria Brogsdale at gloria.f.brogsdale.civ@health.mil for further information.
    Blood Coagulation Analyzer and Reagents
    Buyer not available
    The Department of Defense, through the Medical Readiness Contracting Office - East (MRCO-E), is seeking proposals for a firm fixed-price contract to supply a blood coagulation analyzer and associated reagents for the Womack Army Medical Center located in Fort Liberty, North Carolina. The contractor will be responsible for providing all necessary personnel, equipment, maintenance, transportation, tools, and training to ensure the effective operation of automated analyzers for coagulation testing, with reagents ordered on an as-needed basis. This procurement is crucial for maintaining high-quality medical testing solutions in a military healthcare setting, ensuring compliance with federal regulations, including FDA standards. Interested vendors should refer to the attached solicitation (W91YTZ-25-Q-A045) for detailed requirements and submission guidelines, with the contract period of performance spanning from May 1, 2024, to July 31, 2030. For further inquiries, contact Victoria Manigault at victoria.g.manigault.civ@health.mil or Michael J. McCollum at michael.j.mccollum12.civ@health.mil.
    Hematology Analyzer Leasing
    Buyer not available
    The Department of Defense, specifically the Department of the Air Force, is seeking quotations for the leasing of Hematology Analyzers at Holloman Air Force Base in New Mexico. The procurement requires vendors to provide detailed service documentation and ensure compliance with a comprehensive Statement of Work (SOW), which includes installation, maintenance, and operational requirements for the analyzers, emphasizing accuracy and regulatory compliance. This opportunity is critical for maintaining high-quality healthcare services within military facilities, with a small business size standard of $41.5 million under NAICS code 621511. Interested vendors must submit their proposals via email by 12:00 PM Mountain Time on March 28, 2025, and direct any questions to SSgt Erick Vasquez at erick.vasquez@us.af.mil or Callie M. Spencer at callie.spencer.1@us.af.mil by March 18, 2025.
    Lab Chemistry Analyzer and Cost-Per-Test Agreement for Robins Air Force Base
    Buyer not available
    The Department of Defense, through the Defense Health Agency (DHA), is seeking a sole source contract for a VITROS ® XT 3400 Chemistry Analyzer and a Cost-Per-Test Agreement for the 78th Medical Group Laboratory at Robins Air Force Base in Georgia. The procurement aims to provide a comprehensive laboratory solution that includes the analyzer, reagents, calibrators, controls, and preventive maintenance, all compliant with the Military Health System (MHS) GENESIS electronic health record system. This equipment is crucial for enhancing laboratory analysis capabilities, ensuring efficient and accurate diagnostic testing in support of healthcare services. Interested vendors must submit a Capabilities Statement by 10:00 AM EST on March 24, 2025, to the primary contact, Brittany Belsches, at brittany.n.belsches.civ@health.mil, or Lenore Y. Paseda at lenore.y.paseda.civ@health.mil.
    Whole Blood Collection Bags
    Buyer not available
    The Department of Defense, specifically the Department of the Army, is seeking qualified contractors to supply whole blood collection bags for the Armed Services Blood Bank Center-Pacific Northwest at Madigan Army Medical Center in Washington. The procurement includes 6,600 FDA-approved leukoreduction collection bags with a 500 mL primary container volume, along with necessary adapters that must interface with existing medical equipment, adhering to industry standards and regulatory requirements. This initiative is crucial for ensuring the delivery of quality blood products to support military healthcare operations. Interested bidders must submit their quotations by March 14, 2025, with delivery scheduled from April 1, 2025, to March 31, 2026. For further inquiries, contact Matthew Kohler at matthew.e.kohler2.civ@health.mil or George Rutt at george.r.rutt.civ@health.mil.
    Brand Name or Equivalent of Bio-Rad Evolis and Geenius serological automated analyzers with UPS backup systems for the Walter Reed Army Institute of Research (WRAIR)
    Buyer not available
    The Department of Defense, through the Defense Health Agency, is seeking sources for the procurement of Bio-Rad Evolis and Geenius serological automated analyzers, along with uninterrupted power supply (UPS) backup systems, for the Walter Reed Army Institute of Research (WRAIR) in Silver Spring, Maryland. The requirement includes high-volume HIV testing and confirmation capabilities, with specifications for independent processing systems, automated sample integrity detection, and compatibility with existing laboratory systems, all while adhering to FDA regulations for HIV screening. This initiative is crucial for enhancing infectious disease management among U.S. service members, particularly concerning HIV and hepatitis C. Interested vendors should contact Brenda Mena at brenda.i.mena.civ@health.mil or Sharew Hailu at sharew.hailu.civ@health.mil for further details, as the contract is expected to span from September 30, 2025, to September 29, 2030.
    Hematology Testing - Cost Per Reportable Result
    Buyer not available
    The Department of Defense, specifically the U.S. Army, is soliciting proposals for an automated hematology analyzer system to be delivered to the U.S. Army Health Clinic in Vicenza, Italy. The contract requires the contractor to provide, install, and maintain the analyzer, along with supplying necessary reagents and materials for hematology testing, with an ordering period from May 1, 2025, to September 30, 2029, and a minimum contract value of $1,000. This procurement is critical for enhancing healthcare capabilities at the clinic, ensuring compliance with federal regulations, including HIPAA, and maintaining patient confidentiality. Interested parties, particularly small businesses, service-disabled veteran-owned, and women-owned enterprises, should contact Elena Raspitha at elena.m.raspitha.civ@health.mil for further details.
    65--ANALYZER,INTRAVENOU
    Buyer not available
    The Department of Defense, through the Defense Logistics Agency (DLA Troop Support), is seeking quotes for the procurement of an Intravenous Analyzer (NSN 6515016454093). This procurement includes two units to be delivered to the Naval Medical Readiness Logistics, with a delivery timeline of five days after order (ADO). The Intravenous Analyzer is a critical medical device used in various healthcare settings to ensure accurate intravenous therapy, thereby enhancing patient care. Interested vendors are encouraged to submit their quotes electronically, as hard copies of the solicitation will not be available. For inquiries, potential bidders can contact the DLA at DibbsBSM@dla.mil, and all submissions must be made in accordance with the guidelines outlined in the solicitation document.
    FY26 One (1) Waterless Integrated Immunochemistry Analyzer and One (1) Waterless Clinical Chemistry Analyzer W/ Cost Per Reportable Result(s) (CPRR)
    Buyer not available
    The Department of Defense, specifically the Department of the Army, is seeking qualified vendors to provide one waterless integrated immunochemistry analyzer and one waterless clinical chemistry analyzer, along with a cost per reportable result (CPRR) model, for the General Leonard Wood Army Community Hospital in Fort Leonard Wood, Missouri. The procurement aims to enhance laboratory capabilities by supplying advanced analyzers that require no water access, ensuring operational efficiency in a dry system environment, and includes comprehensive support such as reagents, maintenance, and training at no additional cost to the government. This initiative reflects a commitment to improving healthcare quality through advanced laboratory technology, with an anticipated contract period from October 1, 2025, to September 30, 2030. Interested parties must submit a Statement of Capability by March 17, 2024, to Joshua Barbero at joshua.p.barbero.civ@health.mil, and must be registered in the System for Award Management (SAM) to be eligible for contract award.
    CPRR Reagents, Controls, and Consumables for Coagulation Testing at NHTP
    Buyer not available
    The Department of Defense, through the Defense Health Agency, is seeking quotes for a supply purchase order contract for cost-per-reportable results (CPPR) reagents, controls, and consumables for coagulation testing at Naval Hospital Twentynine Palms (NHTP) in California. The procurement includes the leasing of two bench-top coagulation analyzers, FDA-approved reagents, and consumables necessary for testing key assays such as PT, INR, aPTT, D-Dimer, and Fibrinogen, which are vital for monitoring patient hemostasis and thrombosis. This initiative aims to enhance healthcare services for U.S. military personnel and their families, ensuring reliable and efficient testing capabilities while adhering to budgetary constraints. Interested vendors must submit their quotes by March 21, 2025, and can direct inquiries to Tracy Robinson at tracy.m.robinson18.civ@health.mil or CHA-ON Gordon at cha-on.p.gordon2.civ@health.mil.